Rainbow Children's Medicare Limited (NSE:RAINBOW)

Market Cap	129.98B -5.6%
Revenue (ttm)	18.20B +18.3%
Net Income	2.85B +10.9%
EPS	28.11 +11.5%
Shares Out	101.57M
PE Ratio	45.53
Forward PE	37.19
Dividend	3.50 (0.27%)
Ex-Dividend Date	Jul 21, 2026

Volume	219,202
Open	1,304.30
Previous Close	1,314.30
Day's Range	1,266.20 - 1,306.40
52-Week Range	1,084.00 - 1,610.00
Beta	0.14
Analysts	Buy
Price Target	1,755.79 (+37.17%)
Est. Earnings	Oct 28, 2026

About NSE:RAINBOW

Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers medical and healthcare services to children and women. It also provides pediatric services under brand Rainbow Children’s Hospital which include newborn and pediatric intensive care; pediatric multi-specialty services; and pediatric quaternary care, such as multi-organ transplantation. In addition, the company offers women care services under Birthright brand that comprise perinatal care services, such...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1998
• Employees: 4,724
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: RAINBOW

Financial Performance

In fiscal year 2026, NSE:RAINBOW's revenue was 17.03 billion, an increase of 12.35% compared to the previous year's 15.16 billion. Earnings were 2.78 billion, an increase of 14.34%.

Analyst Summary

According to 14 analysts, the average rating for RAINBOW stock is "Buy." The 12-month stock price target is ₹1,756, which is an increase of 37.17% from the latest price.

Price Target

₹1,756

(37.17% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 2, 2026

Data Sources Report a data error